P-glycoprotein, multidrug resistance and tumor progression

Cancer and Metastasis Reviews

Volumn 13, Issue 2, 1994, Pages 223-233

  Bradley, Grace ^a   Ling, Victor ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

multidrug resistance; P glycoprotein; rat liver carcinogenesis

Indexed keywords

DOXORUBICIN; GLYCOPROTEIN P;

ANIMAL CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; COLON CARCINOMA; DRUG RESISTANCE; EXPERIMENTAL NEOPLASM; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SYNTHESIS; REVIEW; TUMOR VASCULARIZATION;

ANIMAL; ANTINEOPLASTIC AGENTS; DRUG RESISTANCE, MULTIPLE; HUMAN; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; P-GLYCOPROTEIN;

EID: 0028307740     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/BF00689638     Document Type: Article

References (46)

1. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines
2. The biochemistry of P-glycoprotein??mediated multidrug resistance
3. Clinical significance of P-glycoprotein in multidrug resistance malignancies
4. Multidrug resistance and chemosensitization: therapeutic implications for cancer chemotherapy
5. Fluorescent cellular indicators are extruded by the multidrug resistance protein
6. Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone
7. Differential expression of P-glycoprotein genes in primary rat hepatocyte culture
8. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues
9. The three mouse multidrug resistance (mdr) genes are expressed in a tissue specific manner in normal mouse tissues
10. Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues
11. Sex dependent and independent expression of P-glycoprotein isoforms in Chinese hamster
12. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes
13. Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype
14. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
15. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR)
16. Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter
17. Identification of a novel ATP-binding Cassette transporter gene overexpressed in a multidrug resistant human lung cancer cell line
18. P-Glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil
19. Immunohistochemical detection of P-glycoprotein: prognostic correlation in soft tissue sarcoma of childhood
20. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma
21. Expression of the multidrug transporter, P-glycoprotein in chronic myelogenous leukaemia cells in blast crisis
22. Expression of the multidrug resistance-associated P-glycoprotein (P-170) in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications
23. Clinical significance of multidrug resistance P-glycoprotein expression on acute nonlymphoblastic leukemia cells at diagnosis
24. Immunohistochemical identification of P-glycoprotein in previously untreated diffuse large cell and immunoblastic lymphomas
25. P-glycoprotein in human sarcoma: Evidence for multidrug resistance
26. Expression of a multidrug resistance gene in human tumors
27. Expression of a drug resistance gene in human neuroblastoma cell lines: modulation by retinoic acid-induced differentiation
28. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis
29. P-glycoprotein expression during tumor progression in the rat liver
30. Cellular pattern of multidrug-resistance gene expression during chemical hepatocarcinogenesis in the rat
31. Activation of multidrug resistance (P-glycoprotein) mdr3/mdr1a gene during the development of hepatocellular carcinoma in hepatitis B virus transgenic Mice
32. Regulation of 2-acetylaminofluorene- and 3-methylcholanthrene-mediated induction of multidrug resistance and cytochrome P450IA gene family expression in primary hepatocyte cultures and rat liver
33. Cloning and regulation of the rat mdr2 gene
34. Cellular biochemistry of the stepwise development of cancer with chemicals
35. Critical factors in the biology of human cancer metastasis
36. Multidrug resistance gene expression is controlled by steroid hormones in the secretory epithelium of the uterus
37. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells
38. Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents
39. Overexpression of P-glycoprotein in mammalian tumor cell lines after fractionated X irradiation in vitro
40. P-glycoprotein expression in multidrug-resistant human ovarian carcinoma cell lines
41. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53
42. The core promoter region of the P-Glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53
43. p53 mutations cluster at codon 249 in hepatitis B virus-positive hepatocellular carcinomas from China
44. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors